Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Stanford University
Bristol-Myers Squibb
Filamon LTD
Astellas Pharma Inc
Novartis
Fondazione del Piemonte per l'Oncologia
PMV Pharmaceuticals, Inc
Novartis
Kivu Bioscience Inc.
National Institutes of Health Clinical Center (CC)
UMC Utrecht
AstraZeneca
BeOne Medicines
Genmab
University of California, Irvine
ViroMissile, Inc.
Hummingbird Bioscience
Memorial Sloan Kettering Cancer Center
Jazz Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
University of Florida
Myeloid Therapeutics
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Clasp Therapeutics, Inc.
Ulsan University Hospital
Wake Forest University Health Sciences
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
Poitiers University Hospital
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Alliance for Clinical Trials in Oncology
Iambic Therapeutics, Inc
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
Institut Curie
University of Nebraska
Oscotec Inc.
EXoPERT
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau